ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,309, issued on June 17, was assigned to Keygene N.V. (Wageningen, Netherlands).
"Method for targeted alteration of duplex DNA" was invented by Paul Bundock (Wageningen, Netherlands).
According to the abstract* released by the U.S. Patent & Trademark Office: "The current invention relates to methods of targeted genetic alteration in plant cells, as well as to plant cells and plants thus obtained. In the method, a Cpf1 protein and a crRNA is employed to provide for targeted alteration, in particular increased biallelic alteration, of a DNA duplex with increased efficacy."
The patent was filed on June 21, 2019, under Application No. 16/449,326.
*For further information, including ...